Table 2.
Sociodemographic and clinical characteristics of the patients.
| Characteristics | Overall (N=82,182) | TeleCOVID-MG group (n=14,493) | Control group (n=67,689) | P valuea | ||||||
| Age (years), median (IQR) | 38 (28-51) | 37 (27-49) | 39 (29-51) | <.001 | ||||||
| Women, n (%) | 44,847 (54.6) | 8854 (61.1) | 35,993 (53.2) | <.001 | ||||||
| City of flu syndrome notification, n (%) | <.001 | |||||||||
|
|
Divinópolis | 46,313 (56.4) | 3662 (25.3) | 42,651 (63.0) |
|
|||||
|
|
Teófilo Otoni | 25,276 (30.8) | 6269 (43.3) | 19,007 (28.1) |
|
|||||
|
|
Other | 10,593 (12.9) | 4562 (31.5) | 6031 (8.9) |
|
|||||
| City of residence, n (%) | <.001 | |||||||||
|
|
Divinópolis | 47,507 (57.8) | 6091 (42.0) | 41,416 (61.2) |
|
|||||
|
|
Teofilo Otoni | 27,232 (33.1) | 8205 (56.6) | 19,027 (28.1) |
|
|||||
|
|
Other | 7443 (9.1) | 197 (1.4) | 7246 (10.7) |
|
|||||
| Underlying medical conditions, n (%) | ||||||||||
|
|
Chronic respiratory diseases | 1272 (1.5) | 253 (1.7) | 1019 (1.5) | .03 | |||||
|
|
Chronic cardiovascular diseases | 2794 (3.4) | 581 (4.0) | 2213 (3.3) | <.001 | |||||
|
|
Diabetes | 2107 (2.6) | 448 (3.1) | 1659 (2.5) | <.001 | |||||
|
|
Chronic kidney disease | 203 (0.2) | 20 (0.1) | 183 (0.3) | .004 | |||||
|
|
Immunosuppression | 431 (0.5) | 82 (0.6) | 349 (0.5) | .45 | |||||
|
|
High-risk pregnancy | 407 (0.5) | 103 (0.7) | 304 (0.4) | <.001 | |||||
|
|
Chromosomal diseases | 139 (0.2) | 28 (0.2) | 111 (0.2) | .44 | |||||
| Clinical outcomes, n (%) | ||||||||||
|
|
Hospital admission | 1980 (2.4) | 269 (1.9) | 1711 (2.5) | <.001 | |||||
|
|
Death | 1978 (2.4) | 299 (2.1) | 1679 (2.5) | .003 | |||||
aP values are based on the Pearson χ2 test for categorical variables or the Wilcoxon rank sum test for the continuous variable (age).